Helicobacter pylori protection against reflux esophagitis

Digestive Diseases and Sciences

Volumn 57, Issue 11, 2012, Pages 2924-2928

  Ashktorab, Hassan ^a   Entezari, Omid ^a   Nouraie, Mehdi ^b   Dowlati, Ehsan ^a   Frederick, Wayne ^a   Woods, Alfreda ^a   Lee, Edward ^b   Brim, Hassan ^b   Smoot, Duane T ^c   Ghadyari, Firoozeh ^a   Kamangar, Farin ^d   Razjouyan, Hadie ^a  

^a HOWARD UNIVERSITY CANCER CENTER   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d MORGAN STATE UNIVERSITY   (United States)

Author keywords

African Americans; H. pylori; Reflux esophagitis

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGITIS; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL ACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH BIOPSY; STOMACH PROTECTION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 84871623511     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2349-3     Document Type: Article

References (38)

1. Ashktorab H, Dashwood RH, Dashwood MM, et al. H. pyloriinduced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria. Helicobacter. 2008;13:506-517. doi:10.1111/j.1523- 5378.2008.00646.x.
2. Kamangar F, Sheikhattari P, Mohebtash M. Helicobacter pylori and its effects on human health and disease. Arch Iran Med. 2011;14:192-199.
3. Lee SA, Kang D, Shim KN, Choe JW, Hong WS, Choi H. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol. 2003;13:162-168.
4. Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in noncardia gastric cancer in Japan. Gastric Cancer. 2004;7:46-53. doi:10.1007/s10120-004-0268-5.
5. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267-1271. doi:10.1056/ NEJM199405053301803.
6. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep. 2006;7:956-960. doi:10.1038/sj. embor.7400812.
7. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053. doi:10.1002/(SICI)1097-0142 (19981115)83:10\2049:AID-CNCR1[3. 0.CO;2-2.
8. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329-338. doi:10.1158/1940-6207. CAPR-08-0109.
9. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137-2150. doi: 10.1200/JCO.2005.05.2308.
10. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer. 2002;102:422-427. doi:10.1002/ijc.10721.
11. Zhuo X, Zhang Y, Wang Y, Zhuo W, Zhu Y, Zhang X. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol (R Coll Radiol). 2008;20:757-762. doi:10.1016/j.clon. 2008.07.005.
12. Abe Y, Ohara S, Koike T, et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol. 2004;99: 1213-1221. doi:10.1111/j.1572- 0241.2004.30313.xAJG30313.
13. Ackermark P, Kuipers EJ, Wolf C, et al. Colonization with cagApositive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction. Am J Gastroenterol. 2003;98:1719-1724. doi:10.1111/j.1572-0241.2003.07585.x.
14. Rajendra S, Ackroyd R, Robertson IK, Ho JJ, Karim N, Kutty KM. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the east. Helicobacter. 2007;12:177-183. doi:10.1111/j.1523-5378.2007.00489.x.
15. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology. 2010;139:1894-1901; e2; quiz e12. doi:10.1053/j.gastro. 2010.08.018.
16. Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998;93:394-400. doi:10.1111/j.1572-0241.1998.00394.x.
17. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication? A meta-analysis. Am J Gastroenterol. 2010;105:1007-1013; quiz 6, 14. doi:10.1038/ajg.2009.734.
18. Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729-735.
19. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997;112:1442-1447.
20. Raghunath AS, Green JR, Edwards SJ. A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis. Clin Ther. 2003;25:2088-2101.
21. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol. 2002;97:2992-2997. doi:10.1111/j.1572-0241.2002.07116.x.
22. Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Moghaddam S. Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey. Arch Iran Med. 2007;10:289-294.
23. Smith JG, Li W, Rosson RS. Prevalence, clinical and endoscopic predictors of Helicobacter pylori infection in an urban population. Conn Med. 2009;73:133-137.
24. Fan X, Snyder N. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci. 2009;54:572-577. doi:10.1007/s10620-008-0395-7.
25. Sharma P, Wani S, Romero Y, Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol. 2008;103:2669-2680. doi:10.1111/j.1572-0241.2008.02089.x.
26. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831. doi:10.1056/NEJM 199903183401101.
27. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398-407. doi:10.1016/j.cgh.2005.10.011.
28. Entezari O. Helicobacter pylori may protect African Americans from reflux esophagitis, a hospital based study. Gastroenterology. 2009;136(5):A-552.
29. IARC. IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals Lyon. IARC Monogr Eval Carcinog Risks Hum. 1994;60:1-560.
30. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ. 2003;326:737. doi:10.1136/bmj.326.7392.737326/7392/737.
31. Ando T, El-Omar EM, Goto Y, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut. 2006;55:158-164. doi:10.1136/gut.2005.072942.
32. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008;27:173-185. doi:10.1111/j.1365-2036. 2007.03561.x.
33. Ashktorab H, Nouri Z, Nouraie M, et al. Esophageal carcinoma in African Americans: a five-decade experience. Dig Dis Sci. 2011;56(12):3577-3582. doi:10.1007/s10620-011-1853-1.
34. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588-590.
35. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007;132:2116-2130. doi:10.1053/j.gastro.2007. 03.048.
36. El-Serag H. Role of obesity in GORD-related disorders. Gut. 2008;57:281-284. doi:10.1136/gut.2007.127878.
37. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100:1243-1250. doi:10.1111/j.1572-0241.2005.41703.x.
38. El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002;37:899-904.